To the full analysis
Aurubis stock: growth
NDA.DEAurubis reported $20.14B in revenue for fiscal 2025, up 6% on the prior year, up 7.9% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
6.2%
per year from 2006 to 2025, per share 5.3%
Earnings (Annual rate)
5.6%
per year from 2006 to 2025, per share 4.7%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 7.9% | 5.2% | 6.2% |
| Revenue per share | 8.3% | 5.5% | 5.3% |
| Earnings | 15.2% | 15.1% | 5.6% |
| Earnings per share | 15.7% | 15.4% | 4.7% |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $6.37B | $211.75M | −$20.11M |
| 2007 | $7.17B | $246.16M | $383.7M |
| 2008 | $9.29B | $189.24M | $382.33M |
| 2009 | $7.41B | −$51.09M | $532.18M |
| 2010 | $10.93B | $360.96M | −$72.75M |
| 2011 | $15.01B | $357.27M | $334.83M |
| 2012 | $15.28B | $400.16M | $237.84M |
| 2013 | $13.68B | −$170.51M | −$300.78M |
| 2014 | $12.56B | $47.24M | $304.28M |
| 2015 | $12.18B | $146.75M | $280.53M |
| 2016 | $10.5B | $135.02M | $103.19M |
| 2017 | $12.23B | $388.81M | $348.85M |
| 2018 | $11.55B | $321.63M | $38.04M |
| 2019 | $11.93B | $211.18M | $55.62M |
| 2020 | $13.77B | $293.84M | $253.74M |
| 2021 | $18.14B | $679.04M | $620.14M |
| 2022 | $20.52B | $791.92M | −$65.63M |
| 2023 | $18.96B | $156.17M | −$57.93M |
| 2024 | $18.99B | $461.08M | −$342.62M |
| 2025 | $20.14B | $597.27M | −$91.97M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 30 Sep 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 18 Sep 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.